Immune Dysregulation During Sepsis: A Natural History Cohort
Key facts
- Who runs it
- National Heart, Lung, and Blood Institute (NHLBI)
- Where
- Falls Church, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 500 people, planned
- Starts
- 1 Jan 2027
- Expected to end
- 31 Jan 2037
- Type of study
- Observational
- Record updated
- 9 October 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who cannot take part
- Currently receiving infusion of epinephrine; or dopamine at an infusion rate of > 2.5; microgram/kg/min, norepinephrine of > 20 mircogram/min, or vasopressin > 0.04 units/min
- Baseline cognitive impairment
- Hemoglobin < 7 microgram/dL at the time of enrollment
- Hemoglobin <10 microgram/dL in patients with known coronary artery disease or active EKG changes consistent with acute ischemia
- Neutropenia (absolute neutrophil count less than 1000 cells/microliter)
- Any individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Age >= 18 years old
- Admitted to INOVA Fairfax Hospital
- Meets sepsis-3 definition of sepsis in the last 48 hours; Suspected infection; Evidence of organ dysfunction (SOFA score >= 2)
- Ability of subject or LAR to understand and the willingness to sign a written informed consent document
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- Inova Fairfax HospitalFalls Church, United StatesContact: Chris KingNot yet recruiting
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Sepsis is an illness that occurs when the body s immune system runs out of control. This can damage organs. Sepsis causes an estimated 1 in 5 deaths worldwide. In this natural history study, researchers want to learn more about how the immune system changes during sepsis. They hope this knowledge will help them find better ways to treat sepsis.
Objective:
To understand how sepsis affects the body over time.
Eligibility
People aged 18 years and older admitted to INOVA Fairfax Hospital in Virginia and who have sepsis.
Design:
Researchers will collect data from participants medical records.
Participants will have blood drawn at least 5 times while they are in the hospital. Blood may be collected for up to 30 days, if they remain in the hospital that long. The blood will be taken from access lines that are already in place. Some blood draws will be optional.
Participants may opt to have up to 3 tests of their heart function while they are in the hospital.
Some participants may have a sample of fluid collected from their lungs.
Participants will have a follow-up visit about 90 days after they join the study. This visit will be by phone call if they have left the hospital. They will fill out a questionnaire. They will answer questions about their health and how they feel. The call will last about 30 minutes.
The group in the trial
- Participants with Sepsis
Sepsis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07735741, who can take part
- Record updated
- 9 October 2026